NDC 69097-655

Ritonavir film coated

Ritonavir 100 Mg

Ritonavir film coated is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Cipla Usa Inc.. The primary component is Ritonavir.

Product ID69097-655_127233bc-ed5c-470a-bc45-3313b08346b7
NDC69097-655
Product TypeHuman Prescription Drug
Proprietary NameRitonavir film coated
Generic NameRitonavir 100 Mg
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2022-03-23
Marketing CategoryANDA /
Application NumberANDA202573
Labeler NameCipla USA Inc.
Substance NameRITONAVIR
Active Ingredient Strength100 mg/1
Pharm ClassesBreast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 69097-655-02

30 TABLET in 1 CONTAINER (69097-655-02)
Marketing Start Date2022-04-25
NDC Exclude FlagN
Sample Package?N

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.